Embecta Corp. (EMBC)
5.685
-0.06
(-1.13%)
USD |
NASDAQ |
Oct 09, 16:00
5.75
+0.06
(+1.14%)
After-Hours: 20:00
Embecta Cash from Operations (Quarterly) : 41.80M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 41.80M |
| March 31, 2026 | 31.10M |
| December 31, 2025 | 17.20M |
| September 30, 2025 | 84.00M |
| June 30, 2025 | 81.20M |
| March 31, 2025 | 31.80M |
| December 31, 2024 | -5.30M |
| September 30, 2024 | 26.60M |
| June 30, 2024 | -2.10M |
| March 31, 2024 | 24.30M |
| December 31, 2023 | -13.10M |
| Date | Value |
|---|---|
| September 30, 2023 | 29.60M |
| June 30, 2023 | -9.30M |
| March 31, 2023 | -13.00M |
| December 31, 2022 | 60.40M |
| September 30, 2022 | 58.00M |
| June 30, 2022 | 32.80M |
| March 31, 2022 | 182.60M |
| December 31, 2021 | 138.80M |
| September 30, 2021 | 85.20M |
| June 30, 2021 | 129.70M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Artivion, Inc. | -1.266M |
| Abbott Laboratories | 2.488B |
| AngioDynamics, Inc. | -15.33M |
| Alphatec Holdings, Inc. | 20.51M |
| AtriCure, Inc. | 22.19M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -129.50M |
| Cash from Financing (Quarterly) | 112.40M |
| Free Cash Flow | 164.60M |
| Free Cash Flow Per Share (Quarterly) | 0.6956 |
| Free Cash Flow to Equity (Quarterly) | -88.50M |
| Free Cash Flow to Firm (Quarterly) | 58.97M |
| Free Cash Flow Yield | 49.08% |